{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:10:52Z","timestamp":1794978652874,"version":"4.9.1"},"reference-count":55,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Novel therapies for multiple myeloma (MM) aim to engage antitumor functions of T cells. However, evidence indicates these functions are limited within the bone marrow (BM) environment. This is relatively hypoxic in health, and studies indicate widespread hypoxia in MM. In this study, CD8+ T-cell responses to stimulation were assessed under hypoxia, which identified that activation, proliferation, and interferon-gamma (IFN-\u03b3) secretion were profoundly suppressed, while cytotoxicity and tumor necrosis factor-\u03b1 (TNF-\u03b1) expression were unaffected. These changes occurred alongside decreased mechanistic target of rapamycin (mTOR) activity and expression of c-Myc, which drives T-cell metabolic reprogramming upon stimulation. Consistently, hypoxic CD8+ T cells demonstrated decreased activation-induced glycolysis and mitochondrial glutamine oxidation. Mechanistically, this was linked to elevated BCL2\/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) expression under hypoxia, and reciprocally decreased abundance of its interaction partner, Ras homolog enriched in brain (Rheb), an important mTOR activator. Assessment of BCMA\u00d7CD3 bispecific antibody activity confirmed impaired capacity to elicit CD8+ T-cell activation, IFN-\u03b3 expression, proliferation, and altered memory differentiation under hypoxia, although initial target cell killing was unaffected. Finally, assessment of BM CD8+ T cells from patients with MM identified decreased proliferation, c-Myc, and Rheb expression compared with peripheral blood cells, alongside elevated BNIP3, confirming mechanistic features of hypoxic exposure in this environment. Taken together, the findings indicate potential for BM hypoxia to influence efficacy of T cell\u2013directed therapies for MM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016439","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:30:04Z","timestamp":1757694604000},"page":"6175-6188","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["mTOR activity and metabolic reprogramming of CD8+ T cells is impaired under hypoxia and within the multiple myeloma bone marrow"],"prefix":"10.1182","volume":"9","author":[{"given":"Taylor","family":"Fulton-Ward","sequence":"first","affiliation":[{"name":"1Department of Immunology and Immunotherapy, School of Immunity, Infection and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"},{"name":"2Department of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-5241","authenticated-orcid":false,"given":"Nancy","family":"Gudgeon","sequence":"additional","affiliation":[{"name":"1Department of Immunology and Immunotherapy, School of Immunity, Infection and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"},{"name":"2Department of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Thirlwell","sequence":"additional","affiliation":[{"name":"1Department of Immunology and Immunotherapy, School of Immunity, Infection and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"},{"name":"2Department of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Bishop","sequence":"additional","affiliation":[{"name":"1Department of Immunology and Immunotherapy, School of Immunity, Infection and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"},{"name":"2Department of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Marzullo","sequence":"additional","affiliation":[{"name":"2Department of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Giles","sequence":"additional","affiliation":[{"name":"3Centre for Clinical Haematology, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"McIlroy","sequence":"additional","affiliation":[{"name":"3Centre for Clinical Haematology, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ferguson","sequence":"additional","affiliation":[{"name":"3Centre for Clinical Haematology, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvan","family":"Kishore","sequence":"additional","affiliation":[{"name":"3Centre for Clinical Haematology, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8440-0238","authenticated-orcid":false,"given":"Kate","family":"Rogers","sequence":"additional","affiliation":[{"name":"3Centre for Clinical Haematology, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Alfasi","sequence":"additional","affiliation":[{"name":"3Centre for Clinical Haematology, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Wong","sequence":"additional","affiliation":[{"name":"3Centre for Clinical Haematology, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satnam","family":"Aytain","sequence":"additional","affiliation":[{"name":"3Centre for Clinical Haematology, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-2732","authenticated-orcid":false,"given":"Daniel A.","family":"Tennant","sequence":"additional","affiliation":[{"name":"2Department of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6937-2852","authenticated-orcid":false,"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[{"name":"3Centre for Clinical Haematology, University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4598-6518","authenticated-orcid":false,"given":"Sarah","family":"Dimeloe","sequence":"additional","affiliation":[{"name":"1Department of Immunology and Immunotherapy, School of Immunity, Infection and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"},{"name":"2Department of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"20","key":"2025120910312483800_bib1","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1182\/bloodadvances.2023009890","article-title":"Uptake of long-chain fatty acids from the bone marrow suppresses CD8+ T-cell metabolism and function in multiple myeloma","volume":"7","author":"Gudgeon","year":"2023","journal-title":"Blood Adv"},{"issue":"15","key":"2025120910312483800_bib2","doi-asserted-by":"crossref","first-page":"e167629","DOI":"10.1172\/JCI167629","article-title":"Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy","volume":"133","author":"Robinson","year":"2023","journal-title":"J Clin Invest"},{"issue":"7495","key":"2025120910312483800_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"issue":"1","key":"2025120910312483800_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood.V99.1.394","article-title":"Oxygen saturation in the bone marrow of healthy volunteers","volume":"99","author":"Harrison","year":"2002","journal-title":"Blood"},{"issue":"4 pt 1","key":"2025120910312483800_bib5","doi-asserted-by":"crossref","first-page":"C1172","DOI":"10.1152\/ajpcell.1996.271.4.C1172","article-title":"Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension","volume":"271","author":"Jiang","year":"1996","journal-title":"Am J Physiol"},{"issue":"5","key":"2025120910312483800_bib6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1113\/expphysiol.2006.033498","article-title":"Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1","volume":"91","author":"Semenza","year":"2006","journal-title":"Exp Physiol"},{"issue":"Pt 6","key":"2025120910312483800_bib7","first-page":"1454","article-title":"A dynamic model of the hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) network","volume":"126","author":"Nguyen","year":"2013","journal-title":"J Cell Sci"},{"issue":"11","key":"2025120910312483800_bib8","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/leu.2010.193","article-title":"Low bone marrow oxygen tension and hypoxia-inducible factor-1\u03b1 overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells","volume":"24","author":"Colla","year":"2010","journal-title":"Leukemia"},{"issue":"5","key":"2025120910312483800_bib9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3324\/haematol.2009.015628","article-title":"Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells","volume":"95","author":"Martin","year":"2010","journal-title":"Haematologica"},{"issue":"7","key":"2025120910312483800_bib10","first-page":"2831","article-title":"Hypoxia and activated VEGF\/receptor pathway in multiple myeloma","volume":"30","author":"Giatromanolaki","year":"2010","journal-title":"Anticancer Res"},{"issue":"11","key":"2025120910312483800_bib11","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1182\/blood.V104.11.2348.2348","article-title":"Role of the hypoxic bone marrow microenvironment in multiple myeloma tumor progression","volume":"104","author":"Asosingh","year":"2004","journal-title":"Blood"},{"issue":"24","key":"2025120910312483800_bib12","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1182\/blood-2011-09-380410","article-title":"Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features","volume":"119","author":"Azab","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2025120910312483800_bib13","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/leu.2013.76","article-title":"The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis","volume":"27","author":"Kocemba","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"2025120910312483800_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s10020-024-00860-5","article-title":"The implication of serum HLA-G in angiogenesis of multiple myeloma","volume":"30","author":"Wang","year":"2024","journal-title":"Mol Med"},{"issue":"8","key":"2025120910312483800_bib15","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood.V95.8.2630","article-title":"Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma","volume":"95","author":"Dankbar","year":"2000","journal-title":"Blood"},{"issue":"5","key":"2025120910312483800_bib16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1074\/mcp.RA119.001390","article-title":"Metabolic, anti-apoptotic and immune evasion strategies of primary human myeloma cells indicate adaptations to hypoxia","volume":"18","author":"Janker","year":"2019","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"2025120910312483800_bib17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/1078-0432.CCR-18-1325","article-title":"A phase I\/II study of evofosfamide, a hypoxia-activated prodrug with or without bortezomib in subjects with relapsed\/refractory multiple myeloma","volume":"25","author":"Laubach","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2025120910312483800_bib18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ni.2714","article-title":"Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen","volume":"14","author":"Doedens","year":"2013","journal-title":"Nat Immunol"},{"issue":"5","key":"2025120910312483800_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","article-title":"An HIF-1\u03b1\/VEGF-A axis in cytotoxic T cells regulates tumor progression","volume":"32","author":"Palazon","year":"2017","journal-title":"Cancer Cell"},{"issue":"11","key":"2025120910312483800_bib20","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.celrep.2017.08.071","article-title":"Culturing CTLs under hypoxic conditions enhances their cytolysis and improves their anti-tumor function","volume":"20","author":"Gropper","year":"2017","journal-title":"Cell Rep"},{"issue":"3","key":"2025120910312483800_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"issue":"13","key":"2025120910312483800_bib22","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1084\/jem.20112607","article-title":"PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells","volume":"209","author":"Finlay","year":"2012","journal-title":"J Exp Med"},{"key":"2025120910312483800_bib23","doi-asserted-by":"crossref","first-page":"712402","DOI":"10.3389\/fimmu.2021.712402","article-title":"Quantitative analyses reveal how hypoxia reconfigures the proteome of primary cytotoxic t lymphocytes","volume":"12","author":"Ross","year":"2021","journal-title":"Front Immunol"},{"key":"2025120910312483800_bib24","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3389\/fimmu.2020.01906","article-title":"Hypoxia induces mitochondrial defect that promotes T cell exhaustion in tumor microenvironment through MYC-regulated pathways","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"2025120910312483800_bib25","doi-asserted-by":"crossref","first-page":"e84280","DOI":"10.7554\/eLife.84280","article-title":"Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy","volume":"12","author":"Cunha","year":"2023","journal-title":"eLife"},{"issue":"4","key":"2025120910312483800_bib26","doi-asserted-by":"crossref","first-page":"e1283468","DOI":"10.1080\/2162402X.2017.1283468","article-title":"CD69 is a direct HIF-1\u03b1 target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes","volume":"6","author":"Labiano","year":"2017","journal-title":"Oncoimmunology"},{"issue":"19","key":"2025120910312483800_bib27","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.cub.2014.08.007","article-title":"The mTORC1\/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation","volume":"24","author":"Csibi","year":"2014","journal-title":"Curr Biol"},{"issue":"1","key":"2025120910312483800_bib28","doi-asserted-by":"crossref","first-page":"19657","DOI":"10.1038\/s41598-022-24132-6","article-title":"Multiomics analysis couples mRNA turnover and translational control of glutamine metabolism to the differentiation of the activated CD4+ T cell","volume":"12","author":"Matheson","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"2025120910312483800_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2014.12.030","article-title":"The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo","volume":"42","author":"Blagih","year":"2015","journal-title":"Immunity"},{"issue":"7381","key":"2025120910312483800_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10642","article-title":"Reductive carboxylation supports growth in tumour cells with defective mitochondria","volume":"481","author":"Mullen","year":"2011","journal-title":"Nature"},{"issue":"4","key":"2025120910312483800_bib31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.molcel.2018.01.034","article-title":"NADH shuttling couples cytosolic reductive carboxylation of glutamine with glycolysis in cells with mitochondrial dysfunction","volume":"69","author":"Gaude","year":"2018","journal-title":"Mol Cell"},{"issue":"2","key":"2025120910312483800_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"issue":"49","key":"2025120910312483800_bib33","doi-asserted-by":"crossref","first-page":"35803","DOI":"10.1074\/jbc.M705231200","article-title":"Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb","volume":"282","author":"Li","year":"2007","journal-title":"J Biol Chem"},{"issue":"4","key":"2025120910312483800_bib34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1042\/BST20130037","article-title":"Rheb and Rags come together at the lysosome to activate mTORC1","volume":"41","author":"Groenewoud","year":"2013","journal-title":"Biochem Soc Trans"},{"issue":"25","key":"2025120910312483800_bib35","doi-asserted-by":"crossref","first-page":"23433","DOI":"10.1074\/jbc.C500169200","article-title":"Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency","volume":"280","author":"Long","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"2025120910312483800_bib36","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1159\/000464429","article-title":"Hypoxia enhances immunosuppression by inhibiting CD4+ effector T cell function and promoting Treg activity","volume":"41","author":"Westendorf","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"2025120910312483800_bib37","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1007\/s00432-022-04440-0","article-title":"Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy","volume":"149","author":"Davern","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"18","key":"2025120910312483800_bib38","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.1073\/pnas.1811702116","article-title":"Hypoxia-inducible factors in CD4+ T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity","volume":"116","author":"Cho","year":"2019","journal-title":"Proc Natl Acad Sci"},{"issue":"6311","key":"2025120910312483800_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.aaf6284","article-title":"Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"issue":"10","key":"2025120910312483800_bib40","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ni.2687","article-title":"Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch","volume":"14","author":"Gubser","year":"2013","journal-title":"Nat Immunol"},{"issue":"6","key":"2025120910312483800_bib41","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"issue":"9","key":"2025120910312483800_bib42","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.3390\/ijms22094874","article-title":"Role of hypoxia in the control of the cell cycle","volume":"22","author":"Druker","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2025120910312483800_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"issue":"2020","key":"2025120910312483800_bib44","first-page":"e53725","article-title":"Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation","volume":"9","author":"Marchingo","year":"2019","journal-title":"elife"},{"issue":"781","key":"2025120910312483800_bib45","doi-asserted-by":"crossref","first-page":"eabo2709","DOI":"10.1126\/scisignal.abo2709","article-title":"The proliferation of human mucosal-associated invariant T cells requires a MYC-SLC7A5-glycolysis metabolic axis","volume":"16","author":"Kedia-Mehta","year":"2023","journal-title":"Sci Signal"},{"issue":"10","key":"2025120910312483800_bib46","doi-asserted-by":"crossref","first-page":"113211","DOI":"10.1016\/j.celrep.2023.113211","article-title":"Lipid accumulation-mediated histone hypoacetylation drives persistent NK cell dysfunction in anti-tumor immunity","volume":"42","author":"Jiao","year":"2023","journal-title":"Cell Rep"},{"issue":"2","key":"2025120910312483800_bib47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/bloodadvances.2020002832","article-title":"Hypoxia favors chemoresistance in T-ALL through an HIF1\u03b1-mediated mTORC1 inhibition loop","volume":"5","author":"Fahy","year":"2021","journal-title":"Blood Adv"},{"issue":"11","key":"2025120910312483800_bib48","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nrc2501","article-title":"Hypoxia signalling through mTOR and the unfolded protein response in cancer","volume":"8","author":"Wouters","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2025120910312483800_bib49","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/bloodadvances.2020002736","article-title":"A BCMAxCD3 bispecific T cell\u2013engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells","volume":"5","author":"DiLillo","year":"2021","journal-title":"Blood Adv"},{"issue":"4","key":"2025120910312483800_bib50","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2023.02.008","article-title":"The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients","volume":"41","author":"Friedrich","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"2025120910312483800_bib51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10238-024-01501-1","article-title":"Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies","volume":"24","author":"Ciep\u0142a","year":"2024","journal-title":"Clin Exp Med"},{"issue":"4","key":"2025120910312483800_bib52","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.3390\/ijms25042060","article-title":"Therapeutic targeting of hypoxia-inducible factors in cancer","volume":"25","author":"Musleh Ud Din","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2025120910312483800_bib53","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1172\/JCI96268","article-title":"Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy","volume":"128","author":"Jayaprakash","year":"2018","journal-title":"J Clin Invest"},{"issue":"6","key":"2025120910312483800_bib54","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.trsl.2014.12.001","article-title":"Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma","volume":"165","author":"Borsi","year":"2015","journal-title":"Transl Res"},{"issue":"3","key":"2025120910312483800_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/1541-7786.MCR-15-0361","article-title":"A DNA-binding molecule targeting the adaptive hypoxic response in multiple myeloma has potent antitumor activity","volume":"14","author":"Mysore","year":"2016","journal-title":"Mol Cancer Res"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/23\/6175\/2443084\/blooda_adv-2025-016439-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/23\/6175\/2443084\/blooda_adv-2025-016439-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:31:36Z","timestamp":1765294296000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/23\/6175\/547243\/mTOR-activity-and-metabolic-reprogramming-of-CD8-T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":55,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025,12,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016439","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,9]]},"published":{"date-parts":[[2025,12,2]]}}}